InSphero provides superior biological relevance to in vitro testing with its easy-to-use solutions for production, culture and assessment of more organotypic 3D cell culture models. Founded in 2009, the company's patented 3D cell culture platforms and methods enable large-scale, reproducible production of a broad range of assay-ready 3D InSightTM Microtissues including models derived from liver, pancreas, tumor, heart,brain, and skin. Microtissues are delivered directly to customers, or are accessible through 3D InSightTM Standard Services, where InSphero scientists conduct tailored screening projects with rapid turnaround and strict confidentiality. Supported by an unrivalled portfolio of 3D-optimized culture media, assay protocols, and imaging solutions, InSphero microtissues and services help to identify promising drugs and toxic liabilities with greater predictivity at early development stages... read more www.insphero.com/company